Biochemistry

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

1. Xiangyang Chi
2. Renhong Yan
3. Jun Zhang
4. Guanying Zhang
5. Yuanyuan Zhang
6. Meng Hao
7. Zhe Zhang
8. Pengfei Fan
9. Yunzhu Dong
10. Yilong Yang
11. Zhengshan Chen
12. Yingying Guo
13. Jinlong Zhang
14. Yaning Li
15. Xiaohong Song
16. Yi Chen
17. Lu Xia
18. Ling Fu
19. Lihua Hou
20. Junjie Xu
21. Changming Yu
22. Jianmin Li
23. Qiang Zhou
24. Wei Chen

Reviewed by ScreenIT

1. Xiaohan Ren
2. Shangqian Wang
3. Xinglin Chen
4. Xiyi Wei
5. Guangyao Li
6. Shancheng Ren
7. Tongtong Zhang
8. Xu Zhang
9. Zhongwen Lu
10. Zebing You
11. Zengjun Wang
12. Ninghong Song
13. Chao Qin

Reviewed by ScreenIT

Impact of Thiol–Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor

1. Sanchita Hati
2. Sudeep Bhattacharyya

Reviewed by ScreenIT

Repurposing Low-Molecular-Weight Drugs against the Main Protease of Severe Acute Respiratory Syndrome Coronavirus 2

1. Jia Gao
2. Liang Zhang
3. Xiaodan Liu
4. Fudong Li
5. Rongsheng Ma
6. Zhongliang Zhu
7. Jiahai Zhang
8. Jihui Wu
9. Yunyu Shi
10. Yueyin Pan
11. Yushu Ge
12. Ke Ruan

Reviewed by ScreenIT

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

1. Wayne Vuong
2. Muhammad Bashir Khan
3. Conrad Fischer
4. Elena Arutyunova
5. Tess Lamer
6. Justin Shields
7. Holly A. Saffran
8. Ryan T. McKay
9. Marco J. van Belkum
10. Michael A. Joyce
11. Howard S. Young
12. D. Lorne Tyrrell
13. John C. Vederas
14. M. Joanne Lemieux

Reviewed by ScreenIT

Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2

1. Asif Shajahan
2. Stephanie Archer-Hartmann
3. Nitin T Supekar
4. Anne S Gleinich
5. Christian Heiss
6. Parastoo Azadi

Reviewed by ScreenIT

SARS-CoV-2 Spike S1 Receptor Binding Domain undergoes Conformational Change upon Interaction with Low Molecular Weight Heparins

1. Courtney J. Mycroft-West
2. Dunhao Su
3. Yong Li
4. Scott E. Guimond
5. Timothy R. Rudd
6. Stefano Elli
7. Gavin Miller
8. Quentin M. Nunes
9. Patricia Procter
10. Antonella Bisio
11. Nicholas R. Forsyth
12. Jeremy E. Turnbull
13. Marco Guerrini
14. David G. Fernig
15. Edwin A. Yates
16. Marcelo A. Lima
17. Mark A. Skidmore

Reviewed by ScreenIT

Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design

1. Wioletta Rut
2. Zongyang Lv
3. Mikolaj Zmudzinski
4. Stephanie Patchett
5. Digant Nayak
6. Scott J. Snipas
7. Farid El Oualid
8. Tony T. Huang
9. Miklos Bekes
10. Marcin Drag
11. Shaun K. Olsen

Reviewed by ScreenIT

Glycosaminoglycans induce conformational change in the SARS-CoV-2 Spike S1 Receptor Binding Domain

1. Courtney J. Mycroft-West
2. Dunhao Su
3. Yong Li
4. Scott E. Guimond
5. Timothy R. Rudd
6. Stefano Elli
7. Gavin Miller
8. Quentin M. Nunes
9. Patricia Procter
10. Antonella Bisio
11. Nicholas R. Forsyth
12. Jeremy E. Turnbull
13. Marco Guerrini
14. David G. Fernig
15. Edwin A. Yates
16. Marcelo A. Lima
17. Mark A. Skidmore

Reviewed by ScreenIT

Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin

1. Courtney J. Mycroft-West
2. Dunhao Su
3. Isabel Pagani
4. Timothy R. Rudd
5. Stefano Elli
6. Neha S. Gandhi
7. Scott E. Guimond
8. Gavin J. Miller
9. Maria C. Z. Meneghetti
10. Helena B. Nader
11. Yong Li
12. Quentin M. Nunes
13. Patricia Procter
14. Nicasio Mancini
15. Massimo Clementi
16. Antonella Bisio
17. Nicholas R. Forsyth
18. Vito Ferro
19. Jeremy E. Turnbull
20. Marco Guerrini
21. David G. Fernig
22. Elisa Vicenzi
23. Edwin A. Yates
24. Marcelo A. Lima
25. Mark A. Skidmore

Reviewed by ScreenIT